Michael's Hospital, Toronto (Canada) 7 More presentations in this session Professor S
We are grateful to Andreas Diedenhofen and Vincenzo Giordano from the Sigma-Tau Foundation and Sebastian Chapela from the Departamento de Bioquimica Humana, Facultad de Medicina, Universidad de Buenos Aires, UBA, Argentina, for constructive discussion
Introduction and Background GLP-1 receptor agonists (GLP-1 RAs) are a class of peptide-based drugs that mimic the human incretin hormone glucagon-like peptide-1
Previous studies show that QXJYG granules reduce inflammatory factors, modify intestinal flora to alleviate AS, and regulate iron metabolism in macrophages, stabilizing atherosclerotic plaques in individuals with stable coronary artery disease
Why Choose Palm Harbor Pharmacy
Nonetheless, the present study demonstrates that therapeutic inertia represents a significant issue, particularly among non-GLP-1RA users